← Back to Search

Communication Strategies for HPV Vaccination

N/A
Waitlist Available
Led By Noel T Brewer, PhD
Research Sponsored by UNC Lineberger Comprehensive Cancer Center
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be younger than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up from baseline to 12 months
Awards & highlights

Study Summary

This trial compares two ways to improve HPV vaccination communication in primary care. Clinics will receive training from outside expert or internal vaccine champion.

Who is the study for?
This trial is for primary care clinics that serve children aged 9-12, specializing in pediatrics or family medicine. Clinics will be enrolled and their staff trained to communicate about HPV vaccination; however, children won't be directly involved.Check my eligibility
What is being tested?
The study compares two training methods aimed at improving HPV vaccine discussions: one delivered by an external expert and the other by a 'vaccine champion' from within the healthcare system itself.See study design
What are the potential side effects?
Since this trial focuses on communication training rather than medical interventions, there are no direct side effects related to medications or vaccines being studied.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~from baseline to 12 months
This trial's timeline: 3 weeks for screening, Varies for treatment, and from baseline to 12 months for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
HPV vaccination (≥1 dose), 9-12 year olds
Secondary outcome measures
HPV vaccination (2 doses), 9-12 year olds

Trial Design

2Treatment groups
Experimental Treatment
Group I: Traditional AATExperimental Treatment1 Intervention
Staff in clinics randomized to this arm will also receive Announcement Approach Training (AAT). The training will be organized and delivered by outside experts.
Group II: Champion AATExperimental Treatment1 Intervention
Staff in clinics randomized to this arm will receive an intervention called Announcement Approach Training (AAT). This training is designed to improve communication about HPV vaccination. The training will be organized and delivered by vaccine champions from participating healthcare systems.

Find a Location

Who is running the clinical trial?

UNC Lineberger Comprehensive Cancer CenterLead Sponsor
351 Previous Clinical Trials
88,292 Total Patients Enrolled
National Cancer Institute (NCI)NIH
13,657 Previous Clinical Trials
40,933,627 Total Patients Enrolled
University of Wisconsin, MadisonOTHER
1,182 Previous Clinical Trials
3,167,347 Total Patients Enrolled

Media Library

Traditional AAT Clinical Trial Eligibility Overview. Trial Name: NCT05736718 — N/A
Human Papillomavirus Research Study Groups: Traditional AAT, Champion AAT
Human Papillomavirus Clinical Trial 2023: Traditional AAT Highlights & Side Effects. Trial Name: NCT05736718 — N/A
Traditional AAT 2023 Treatment Timeline for Medical Study. Trial Name: NCT05736718 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Who qualifies to participate in this research experiment?

"In order to be enrolled in this medical trial, potential patients should have a positive diagnosis of human papillomavirus and must fall between 9 and 12 years old. Approximately 40 participants need to join before the study is completed."

Answered by AI

Are there any vacancies to participate in this experiment?

"According to clinicaltrials.gov, the trial originally posted on March 15th 2023 is no longer recruiting patients at this time; however there are 91 other studies searching for participants as of February 10th 2023."

Answered by AI

Is enrollment being offered to younger adults for this research?

"To be considered for the trial, participants must fall between 9 and 12 years old. Additionally, 23 studies are recruiting those younger than 18 while 51 studies cater to seniors over 65."

Answered by AI
Recent research and studies
clinicaltrials.govStudy
Engaging Clinical Champions to Improve HPV Vaccination
2023. "Engaging Clinical Champions to Improve HPV Vaccination". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT05736718.
All > Hpv
~21 spots leftby Jun 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top